Pub Date : 2025-08-04DOI: 10.1016/j.abd.2025.501167
Qing Shu , Xiang Zhong , Lixia Zhang , Qian Wang
{"title":"Omalizumab for cholinergic pruritus in a renal transplant and hemodialysis patient","authors":"Qing Shu , Xiang Zhong , Lixia Zhang , Qian Wang","doi":"10.1016/j.abd.2025.501167","DOIUrl":"10.1016/j.abd.2025.501167","url":null,"abstract":"","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":"100 5","pages":"Article 501167"},"PeriodicalIF":3.6,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144768311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-18DOI: 10.1016/j.abd.2025.501164
Dimitri Luz F. Silva , Rafael Rubinho , Ariany Denofre , Sandra Avila , Renata Ferreira Magalhães
Background
Artificial intelligence (AI) is increasingly gaining ground in dermatology, with studies reporting accuracy equal to or greater than dermatologists for the diagnosis of skin lesions from clinical and dermoscopic images.1 AI has been developed and improved constantly for dermatology, however, the focus has been much more on neoplastic diseases, due to their high prevalence and high morbidity.
Objectives
Describe the possible applications of AI in inflammatory dermatoses.
Methods
Articles published between 2013 and 2023 in Medline and Lilacs were retrieved after applying the inclusion and exclusion criteria 19 articles were selected. From each selected article, the necessary information was extracted and with this data, the present review was written.
Results
The first studies on AI in dermatology focused on the diagnosis of neoplasms, especially melanoma, due to the ease of standardization of images, obtaining accuracy equivalent to that of a dermatologist in clinical and dermoscopic lesions. Actually, there are many studies on artificial intelligence in inflammatory dermatosis, such as psoriasis, helping to calculate the PASI, hidradenitis suppurativa, and atopic dematitis.
Study limitations
The limitation of the study is that it is a literature review and because it is an innovative topic with a limited number of studies published in the literature.
Conclusions
Considerable of what is published in the literature is in computer science journals, but it is possible to perceive that there is an important interest in the area and that artificial intelligence will advance to assist dermatologists.
{"title":"Artificial intelligence on inflammatory dermatoses: where we are and where are we going?","authors":"Dimitri Luz F. Silva , Rafael Rubinho , Ariany Denofre , Sandra Avila , Renata Ferreira Magalhães","doi":"10.1016/j.abd.2025.501164","DOIUrl":"10.1016/j.abd.2025.501164","url":null,"abstract":"<div><h3>Background</h3><div>Artificial intelligence (AI) is increasingly gaining ground in dermatology, with studies reporting accuracy equal to or greater than dermatologists for the diagnosis of skin lesions from clinical and dermoscopic images.<span><span><sup>1</sup></span></span> AI has been developed and improved constantly for dermatology, however, the focus has been much more on neoplastic diseases, due to their high prevalence and high morbidity.</div></div><div><h3>Objectives</h3><div>Describe the possible applications of AI in inflammatory dermatoses.</div></div><div><h3>Methods</h3><div>Articles published between 2013 and 2023 in Medline and Lilacs were retrieved after applying the inclusion and exclusion criteria 19 articles were selected. From each selected article, the necessary information was extracted and with this data, the present review was written.</div></div><div><h3>Results</h3><div>The first studies on AI in dermatology focused on the diagnosis of neoplasms, especially melanoma, due to the ease of standardization of images, obtaining accuracy equivalent to that of a dermatologist in clinical and dermoscopic lesions. Actually, there are many studies on artificial intelligence in inflammatory dermatosis, such as psoriasis, helping to calculate the PASI, hidradenitis suppurativa, and atopic dematitis.</div></div><div><h3>Study limitations</h3><div>The limitation of the study is that it is a literature review and because it is an innovative topic with a limited number of studies published in the literature.</div></div><div><h3>Conclusions</h3><div>Considerable of what is published in the literature is in computer science journals, but it is possible to perceive that there is an important interest in the area and that artificial intelligence will advance to assist dermatologists.</div></div>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":"100 5","pages":"Article 501164"},"PeriodicalIF":2.6,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144655929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bullous pemphigoid (BP) is the most prevalent autoimmune bullous dermatosis with increasing incidence globally. There is a lack of literature on BP in the multiethnic Brazilian population.
Objectives
To assess the epidemiological, clinical, and therapeutic characteristics of BP patients in a tertiary center in Brazil.
Methods
Retrospective longitudinal review of clinical records of 189 BP patients from January 1986 to September 2023.
Results
BP primarily affected elderly individuals, predominantly females, with an average onset of symptoms at 65.7-years. Non-bullous presentations had a longer time to diagnose compared to the bullous form. Mucosal involvement was observed in 24.9% of patients. Subepidermal blistering was the predominant histopathological feature. Most cases presented fluorescence of IgG and C3 at the basement membrane zone (BMZ) on direct immunofluorescence. Indirect immunofluorescence mainly revealed fluorescence of IgG along the BMZ, and with salt-split skin technique demonstrated predominantly IgG fluorescence on the epidermal side of the cleavage. Eosinophilia, elevated IgE levels, and D-dimer were common. Systemic corticosteroids remained the mainstay of treatment. BP was associated with significant complications, including thromboembolism, hospitalization, and infections, along with numerous comorbidities and a notable percentage (10.6%) of patients using potentially BP-inducing medications.
Study limitations
The study's limitations include its retrospective design, reliance on potentially incomplete clinical records, and findings of a single tertiary center.
Conclusions
This study provides crucial insights into the multifaceted nature of BP in the Brazilian population, emphasizing the need for comprehensive management strategies to address its diverse complications and associated conditions.
{"title":"Bullous pemphigoid: epidemiological, clinical, and therapeutic analysis of 189 patients in a tertiary center in Brazil","authors":"Cecília Mirelle Almeida Honorato, Claudia Giuli Santi, Celina Wakisaka Maruta, Valeria Aoki, Denise Miyamoto","doi":"10.1016/j.abd.2025.501163","DOIUrl":"10.1016/j.abd.2025.501163","url":null,"abstract":"<div><h3>Background</h3><div>Bullous pemphigoid (BP) is the most prevalent autoimmune bullous dermatosis with increasing incidence globally. There is a lack of literature on BP in the multiethnic Brazilian population.</div></div><div><h3>Objectives</h3><div>To assess the epidemiological, clinical, and therapeutic characteristics of BP patients in a tertiary center in Brazil.</div></div><div><h3>Methods</h3><div>Retrospective longitudinal review of clinical records of 189 BP patients from January 1986 to September 2023.</div></div><div><h3>Results</h3><div>BP primarily affected elderly individuals, predominantly females, with an average onset of symptoms at 65.7-years. Non-bullous presentations had a longer time to diagnose compared to the bullous form. Mucosal involvement was observed in 24.9% of patients. Subepidermal blistering was the predominant histopathological feature. Most cases presented fluorescence of IgG and C3 at the basement membrane zone (BMZ) on direct immunofluorescence. Indirect immunofluorescence mainly revealed fluorescence of IgG along the BMZ, and with salt-split skin technique demonstrated predominantly IgG fluorescence on the epidermal side of the cleavage. Eosinophilia, elevated IgE levels, and D-dimer were common. Systemic corticosteroids remained the mainstay of treatment. BP was associated with significant complications, including thromboembolism, hospitalization, and infections, along with numerous comorbidities and a notable percentage (10.6%) of patients using potentially BP-inducing medications.</div></div><div><h3>Study limitations</h3><div>The study's limitations include its retrospective design, reliance on potentially incomplete clinical records, and findings of a single tertiary center.</div></div><div><h3>Conclusions</h3><div>This study provides crucial insights into the multifaceted nature of BP in the Brazilian population, emphasizing the need for comprehensive management strategies to address its diverse complications and associated conditions.</div></div>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":"100 5","pages":"Article 501163"},"PeriodicalIF":2.6,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144656631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Arsenic, recognized as a potentially lethal substance and a carcinogen, has been associated with an increased risk of skin cancer; however, the findings have been inconsistent. The aim of this study was to assess the impact of arsenic exposure on skin cancer risk (including melanoma and non-melanoma) through a meta-analysis of the available data.
Objectives
To assess the risk of skin cancer from arsenic exposure.
Methods
Searches were performed in databases such as PubMed, Web of Science, Embase, and CNKI (as of June 10, 2024). The pooled odds ratio (OR) and its 95% Confidence Interval (95% CI) were calculated using a random effects model. Subgroup analyses were performed considering sample size, study centers, U.S. regions, arsenic exposure routes, and measurement methods.
Results
A total of 12 papers were included, comprising 48,003 participants. The findings indicated an association between arsenic exposure and the risk of skin cancer ([OR = 1.51], 95% CI 1.26–1.80). Specifically, the OR was 1.52 (95% CI 1.06–2.17) for melanoma, 1.64 (95% CI 1.16–2.32) for squamous cell carcinoma, and 1.36 (95% CI 1.04–1.77) for basal cell carcinoma. Subgroup analyses also revealed an association between arsenic exposure and skin cancer in the United States (OR = 1.52, 95% CI 1.25–1.87). Both ingestion and inhalation pathways of arsenic exposure showed a trend toward an increased risk of skin cancer.
Study limitations
An important limitation of this study is a degree of heterogeneity, and another is due to the limited number of research papers available.
Conclusion
This meta-analysis indicates that arsenic exposure may be associated with an elevated risk of skin cancer. Additional prospective research is necessary to verify the association between arsenic exposure and the incidence of skin cancer, encompassing both cutaneous malignant melanoma and non-melanoma skin cancer.
砷被认为是一种潜在的致命物质和致癌物,与皮肤癌风险增加有关;然而,研究结果并不一致。本研究的目的是通过对现有数据的荟萃分析,评估砷暴露对皮肤癌风险(包括黑色素瘤和非黑色素瘤)的影响。目的评价砷暴露引起皮肤癌的危险性。方法检索PubMed、Web of Science、Embase、CNKI等数据库(截至2024年6月10日)。使用随机效应模型计算合并优势比(OR)及其95%置信区间(95% CI)。根据样本量、研究中心、美国地区、砷暴露途径和测量方法进行亚组分析。结果共纳入论文12篇,纳入受试者48003人。研究结果表明砷暴露与皮肤癌风险之间存在关联([OR = 1.51], 95% CI 1.26-1.80)。具体来说,黑色素瘤的OR为1.52 (95% CI 1.06-2.17),鳞状细胞癌的OR为1.64 (95% CI 1.16-2.32),基底细胞癌的OR为1.36 (95% CI 1.04-1.77)。亚组分析还揭示了砷暴露与美国皮肤癌之间的关联(OR = 1.52, 95% CI 1.25-1.87)。砷暴露的摄入和吸入途径都显示出皮肤癌风险增加的趋势。研究限制本研究的一个重要限制是异质性程度,另一个限制是由于研究论文数量有限。结论本荟萃分析表明,砷暴露可能与皮肤癌风险升高有关。需要进一步的前瞻性研究来验证砷暴露与皮肤癌发病率之间的关系,包括皮肤恶性黑色素瘤和非黑色素瘤皮肤癌。
{"title":"Arsenic exposure and risk of skin cancer (melanoma and non-melanoma): A systematic review and meta-analysis","authors":"Lijiao He, Meiying Wei, Qikui Yang, Yun Huang, Zuyuan Wei","doi":"10.1016/j.abd.2025.501161","DOIUrl":"10.1016/j.abd.2025.501161","url":null,"abstract":"<div><h3>Background</h3><div>Arsenic, recognized as a potentially lethal substance and a carcinogen, has been associated with an increased risk of skin cancer; however, the findings have been inconsistent. The aim of this study was to assess the impact of arsenic exposure on skin cancer risk (including melanoma and non-melanoma) through a meta-analysis of the available data.</div></div><div><h3>Objectives</h3><div>To assess the risk of skin cancer from arsenic exposure.</div></div><div><h3>Methods</h3><div>Searches were performed in databases such as PubMed, Web of Science, Embase, and CNKI (as of June 10, 2024). The pooled odds ratio (OR) and its 95% Confidence Interval (95% CI) were calculated using a random effects model. Subgroup analyses were performed considering sample size, study centers, U.S. regions, arsenic exposure routes, and measurement methods.</div></div><div><h3>Results</h3><div>A total of 12 papers were included, comprising 48,003 participants. The findings indicated an association between arsenic exposure and the risk of skin cancer ([OR = 1.51], 95% CI 1.26–1.80). Specifically, the OR was 1.52 (95% CI 1.06–2.17) for melanoma, 1.64 (95% CI 1.16–2.32) for squamous cell carcinoma, and 1.36 (95% CI 1.04–1.77) for basal cell carcinoma. Subgroup analyses also revealed an association between arsenic exposure and skin cancer in the United States (OR = 1.52, 95% CI 1.25–1.87). Both ingestion and inhalation pathways of arsenic exposure showed a trend toward an increased risk of skin cancer.</div></div><div><h3>Study limitations</h3><div>An important limitation of this study is a degree of heterogeneity, and another is due to the limited number of research papers available.</div></div><div><h3>Conclusion</h3><div>This meta-analysis indicates that arsenic exposure may be associated with an elevated risk of skin cancer. Additional prospective research is necessary to verify the association between arsenic exposure and the incidence of skin cancer, encompassing both cutaneous malignant melanoma and non-melanoma skin cancer.</div></div>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":"100 5","pages":"Article 501161"},"PeriodicalIF":2.6,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144656632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-14DOI: 10.1016/j.abd.2025.501162
Taís Lopes Saranholi , Natalie Carlos Ferreira Mello Sampaio , Hélio Amante Miot , Stéfani Thais Alves Dantas , Vera Lucia Mores Rall , Luciana Patricia Fernandes Abbade
Background
Superficial infection in venous ulcers (VU) hinders healing.
Objective
To evaluate the action of hydrofiber dressing with silver (HAg) compared to collagenase ointment (Col) in VU.
Methods
Randomized controlled clinical trial in which patients with VU with superficial infection were randomized to the intervention (HAg) or comparison (Col) group. After 30 days (T30), the primary outcomes evaluated were: rate of ulcers without signs of superficial infection, decrease in bacterial load, presence of biofilm-producing bacteria, and bacterial clonality.
Results
Thirty-four patients (56 ulcers) were included ‒ 18 patients (28 ulcers) in the HAg group and 16 (28 ulcers) in the Col group. There was a reduction in ulcers with superficial infection in both groups over time but with no differences (p = 0.422). There was no decrease in total bacterial load over time (p = 0.054) or between the groups (p = 0.113). There was a reduction in the rate of ulcers with biofilm-forming bacteria over time (p = 0.047) but no differences between groups (p = 0.558). Regarding the clonality of Staphylococcus aureus, 92.8% of ulcers in the HAg group and 85% in the Col group, the clones identified at T0 were the same at T30 (p = 0.553). There was no change in the identity of Pseudomonas aeruginosa in any ulcer in either group.
Study limitations
Short follow-up time.
Conclusion
Both interventions improved the clinical and some microbiologic characteristics, but there was no difference between both interventions. In addition, most ulcers showed indistinguishable genetic profiles of S. aureus and P. aeruginosa between T0 and T30, with no difference between the groups.
{"title":"A randomized clinical trial of silver hydrofiber dressing versus collagenase ointment for venous ulcer: analysis of biofilm-producing bacteria and bacterial clonality","authors":"Taís Lopes Saranholi , Natalie Carlos Ferreira Mello Sampaio , Hélio Amante Miot , Stéfani Thais Alves Dantas , Vera Lucia Mores Rall , Luciana Patricia Fernandes Abbade","doi":"10.1016/j.abd.2025.501162","DOIUrl":"10.1016/j.abd.2025.501162","url":null,"abstract":"<div><h3>Background</h3><div>Superficial infection in venous ulcers (VU) hinders healing.</div></div><div><h3>Objective</h3><div>To evaluate the action of hydrofiber dressing with silver (HAg) compared to collagenase ointment (Col) in VU.</div></div><div><h3>Methods</h3><div>Randomized controlled clinical trial in which patients with VU with superficial infection were randomized to the intervention (HAg) or comparison (Col) group. After 30 days (T30), the primary outcomes evaluated were: rate of ulcers without signs of superficial infection, decrease in bacterial load, presence of biofilm-producing bacteria, and bacterial clonality.</div></div><div><h3>Results</h3><div>Thirty-four patients (56 ulcers) were included ‒ 18 patients (28 ulcers) in the HAg group and 16 (28 ulcers) in the Col group. There was a reduction in ulcers with superficial infection in both groups over time but with no differences (<em>p</em> = 0.422). There was no decrease in total bacterial load over time (<em>p</em> = 0.054) or between the groups (<em>p</em> = 0.113). There was a reduction in the rate of ulcers with biofilm-forming bacteria over time (<em>p</em> = 0.047) but no differences between groups (<em>p</em> = 0.558). Regarding the clonality of <em>Staphylococcus aureus</em>, 92.8% of ulcers in the HAg group and 85% in the Col group, the clones identified at T0 were the same at T30 (<em>p</em> = 0.553). There was no change in the identity of <em>Pseudomonas aeruginosa</em> in any ulcer in either group.</div></div><div><h3>Study limitations</h3><div>Short follow-up time.</div></div><div><h3>Conclusion</h3><div>Both interventions improved the clinical and some microbiologic characteristics, but there was no difference between both interventions. In addition, most ulcers showed indistinguishable genetic profiles of <em>S. aureus</em> and <em>P. aeruginosa</em> between T0 and T30, with no difference between the groups.</div></div>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":"100 5","pages":"Article 501162"},"PeriodicalIF":2.6,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144623681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-11DOI: 10.1016/j.abd.2025.501160
Renan Rangel Bonamigo , Paula Barea , Juliano Peruzzo , Juliana Boza , Hélio Amante Miot , Edileia Bagatin , Luiz Maurício Costa Almeida , Giovanni Indelicato Milano , Carla Wanderley Gayoso de Lima , Linácia Freitas Vidal , Fabíola Rosa Picosse , Bruna Manuella de Figueiredo Afonso , Clivia Maria Moraes de Oliveira
Background
Rosacea is the most prevalent chronic vascular-inflammatory dermatosis of the face. Its pathogenesis includes genetic and environmental factors, neurovascular alterations, and innate immunity. Many triggering and aggravating factors, as well as systemic comorbidities, have been associated with the disease, but there are few studies on its epidemiology in Brazil.
Objectives
To describe the profile of patients with rosacea treated at referral centers, as well as to investigate the presence of comorbidities, dietary aspects, worsening factors, and quality of life.
Methods
Cross-sectional and multicenter Brazilian study. Clinical and demographic data, disease severity, triggering and/or aggravating factors, diet, comorbidities, and impact on quality of life were evaluated.
Results
258 patients were included, predominantly women, between 35 and 65 years old and phototypes III, IV and II. The clinical picture ranged from mild to moderate in 89% of cases and quality of life was reasonable to slightly affected in 58% of cases. Aggravating factors for rosacea were reported by 96% of patients, with climate exposure, alcoholic beverages, and emotional changes being the most frequent. Among the foods mentioned as aggravating factors (28%), pepper, other condiments and hot beverages were the most frequently reported. Comorbidities were reported by 89% of the participants, with emphasis on endocrine (48%), psychiatric (35%), cardiovascular (31%) and gastrointestinal (28%) diseases.
Study limitations
Uncontrolled study, including patients undergoing dermatological treatment.
Conclusions
This study establishes that the profile of Brazilian patients with rosacea corroborates that described in the literature, with the presence of the disease in higher phototypes being relevant. Pepper and other condiments and hot beverages were important aggravating factors, and the presence of various comorbidities was reported by most of the patients.
{"title":"Clinical-demographic profile, aggravating factors, comorbidities, and quality of life in patients with Rosacea: a Brazilian multicenter study (GBPER: Brazilian Research and Studies Group on Rosacea)","authors":"Renan Rangel Bonamigo , Paula Barea , Juliano Peruzzo , Juliana Boza , Hélio Amante Miot , Edileia Bagatin , Luiz Maurício Costa Almeida , Giovanni Indelicato Milano , Carla Wanderley Gayoso de Lima , Linácia Freitas Vidal , Fabíola Rosa Picosse , Bruna Manuella de Figueiredo Afonso , Clivia Maria Moraes de Oliveira","doi":"10.1016/j.abd.2025.501160","DOIUrl":"10.1016/j.abd.2025.501160","url":null,"abstract":"<div><h3>Background</h3><div>Rosacea is the most prevalent chronic vascular-inflammatory dermatosis of the face. Its pathogenesis includes genetic and environmental factors, neurovascular alterations, and innate immunity. Many triggering and aggravating factors, as well as systemic comorbidities, have been associated with the disease, but there are few studies on its epidemiology in Brazil.</div></div><div><h3>Objectives</h3><div>To describe the profile of patients with rosacea treated at referral centers, as well as to investigate the presence of comorbidities, dietary aspects, worsening factors, and quality of life.</div></div><div><h3>Methods</h3><div>Cross-sectional and multicenter Brazilian study. Clinical and demographic data, disease severity, triggering and/or aggravating factors, diet, comorbidities, and impact on quality of life were evaluated.</div></div><div><h3>Results</h3><div>258 patients were included, predominantly women, between 35 and 65 years old and phototypes III, IV and II. The clinical picture ranged from mild to moderate in 89% of cases and quality of life was reasonable to slightly affected in 58% of cases. Aggravating factors for rosacea were reported by 96% of patients, with climate exposure, alcoholic beverages, and emotional changes being the most frequent. Among the foods mentioned as aggravating factors (28%), pepper, other condiments and hot beverages were the most frequently reported. Comorbidities were reported by 89% of the participants, with emphasis on endocrine (48%), psychiatric (35%), cardiovascular (31%) and gastrointestinal (28%) diseases.</div></div><div><h3>Study limitations</h3><div>Uncontrolled study, including patients undergoing dermatological treatment.</div></div><div><h3>Conclusions</h3><div>This study establishes that the profile of Brazilian patients with rosacea corroborates that described in the literature, with the presence of the disease in higher phototypes being relevant. Pepper and other condiments and hot beverages were important aggravating factors, and the presence of various comorbidities was reported by most of the patients.</div></div>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":"100 5","pages":"Article 501160"},"PeriodicalIF":2.6,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-07DOI: 10.1016/j.abd.2025.501147
Ömer Faruk Kıraç , Mustafa Tosun , Rukiye Yasak Güner , Melih Akyol
Background
The FricTest is used as a valuable tool for diagnosing and conducting threshold testing for Symptomatic Dermographism (SD).
Objective
In this study, the authors aimed to make a comparison between the Urticaria Activity Score (UAS), Urticaria Control Test (UCT), Visual Analog Scale (VAS), Dermatology Life Quality Index (DLQI), and Chronic Urticaria-Specific Quality of Life (CU-QoL) used to evaluate disease activity and control in the follow-up of urticaria patients and the Fric Test responses used in the diagnosis of dermographism.
Methods
71 patients with SD were included in the study. Fric test 4.0 was performed in all patients at baseline and at month 1. The correlations of Fric test scores with UCT, UAS, VAS, DLQI, and CU-QoL at baseline as well as the changes in responses of treatment in the mean scores at month 1 were performed.
Results
In the correlation analyses, positive correlations were observed between UAS, DLQI, and CU-QoL scores and changes in Fric test 4.5 mm and 4 mm responses from baseline to the first month of treatment (p < 0.05). No significant correlations were found between Fric test 3.5 mm and 3 mm responses and CU-QoL, UAS, DLQI, and VAS scores (p > 0.05).
Study limitations
This study includes results from a small sample size, and larger-scale clinical trials are needed.
Conclusion
Changes in the Fric test 4.5 mm and 4 mm responses of treatment were found to be more sensitive in detecting UCT, UAS, CU-QoL, and DLQI changes than the responses of the Fric test 3.5 mm and 3 mm.
{"title":"The relationship of Fric test responses with an urticaria activity score, urticaria control test and quality of life scales in patients with symptomatic dermographism","authors":"Ömer Faruk Kıraç , Mustafa Tosun , Rukiye Yasak Güner , Melih Akyol","doi":"10.1016/j.abd.2025.501147","DOIUrl":"10.1016/j.abd.2025.501147","url":null,"abstract":"<div><h3>Background</h3><div>The FricTest is used as a valuable tool for diagnosing and conducting threshold testing for Symptomatic Dermographism (SD).</div></div><div><h3>Objective</h3><div>In this study, the authors aimed to make a comparison between the Urticaria Activity Score (UAS), Urticaria Control Test (UCT), Visual Analog Scale (VAS), Dermatology Life Quality Index (DLQI), and Chronic Urticaria-Specific Quality of Life (CU-QoL) used to evaluate disease activity and control in the follow-up of urticaria patients and the Fric Test responses used in the diagnosis of dermographism.</div></div><div><h3>Methods</h3><div>71 patients with SD were included in the study. Fric test 4.0 was performed in all patients at baseline and at month 1. The correlations of Fric test scores with UCT, UAS, VAS, DLQI, and CU-QoL at baseline as well as the changes in responses of treatment in the mean scores at month 1 were performed.</div></div><div><h3>Results</h3><div>In the correlation analyses, positive correlations were observed between UAS, DLQI, and CU-QoL scores and changes in Fric test 4.5 mm and 4 mm responses from baseline to the first month of treatment (<em>p</em> < 0.05). No significant correlations were found between Fric test 3.5 mm and 3 mm responses and CU-QoL, UAS, DLQI, and VAS scores (<em>p</em> > 0.05).</div></div><div><h3>Study limitations</h3><div>This study includes results from a small sample size, and larger-scale clinical trials are needed.</div></div><div><h3>Conclusion</h3><div>Changes in the Fric test 4.5 mm and 4 mm responses of treatment were found to be more sensitive in detecting UCT, UAS, CU-QoL, and DLQI changes than the responses of the Fric test 3.5 mm and 3 mm.</div></div>","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":"100 5","pages":"Article 501147"},"PeriodicalIF":2.6,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144569894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-01DOI: 10.1016/j.abd.2025.501145
Julia Aires Thomaz Maya , Kaique Arriel , Laura Stamato de Figueiredo , John Verrinder Veasey
{"title":"Epidemiological profile of anogenital lesions in 4,029 consultations at a Sexually Transmitted Infections Clinic in São Paulo, Brazil","authors":"Julia Aires Thomaz Maya , Kaique Arriel , Laura Stamato de Figueiredo , John Verrinder Veasey","doi":"10.1016/j.abd.2025.501145","DOIUrl":"10.1016/j.abd.2025.501145","url":null,"abstract":"","PeriodicalId":7787,"journal":{"name":"Anais brasileiros de dermatologia","volume":"100 4","pages":"Article 501145"},"PeriodicalIF":2.6,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144588314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}